Use Options For a Chance To Buy BCRX at a 52% Discount

Looking back to 149 days ago, BioCryst Pharmaceuticals, Inc. (NASD: BCRX) priced a $100,000,000 secondary stock offering at $10.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Friday, the stock is now 20.9% above the offering price.